Vaxcyte, Inc. (PCVX) Misses Q4 EPS by 251c

Vaxcyte, Inc. (NASDAQ: PCVX) reported Q4 EPS of ($3.44), $2.51 worse than the analyst estimate of ($0.93).

For earnings history and earnings-related data on Vaxcyte, Inc. (PCVX) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• MapLight Therapeutics, Inc. (MPLT) Misses Q2 EPS by 33c
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance